Videos | EP Lab | August 02, 2021
Jass Brooks, vice president of global strategic marketing, Biosense Webster, explains four over-arching...
Videos | EP Lab | August 02, 2021
Samir Saba, M.D., co-director of the University of Pittsburgh Medical Center Heart and Vascular Institute, and chief,...
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.

In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. 

Feature | Coronavirus (COVID-19) | July 30, 2021 | By Dave Fornell, Editor
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all...
Innovative Health Inc. announced several new initiatives to increase savings from single-use device reprocessing in the electrophysiology (EP) lab. #HRS21 #HRS2021 #Heartrhythm21
News | EP Lab | July 30, 2021
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device...
Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.

Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.

News | EP Lab | July 29, 2021
July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin...
The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right).  #HRS21 #HRS2021 #HeartRhythm21

The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right). 

News | EP Lab | July 29, 2021
July 29, 2021 – Results from a new clinical trial find human-oversight dependent continuous electrocardiography (ECG)...
The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation...
St. Jude Medical Pays $27 Million for Allegedly Selling Defective ICD and CRT-D devices
News | EP Lab | July 28, 2021
July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27...
ScImage Inc., a provider of cloud-centric cardiovascular and radiology enterprise imaging and reporting solutions, announced a partnership with Cardiology Consultants PA (CCPA). The Spartanburg, S.C., cardiology group consists of 14 physicians, six nurse practitioners, three office locations and a newly opened office-based lab/ambulatory surgical center (OBL/ASC) servicing upstate South Carolina and western North Carolina. ScImage provided a CVIS, or cardiovascular information system.
News | Cardiovascular Information Systems (CVIS) | July 28, 2021
July 28, 2021 - ScImage Inc., a provider of cloud-centric cardiovascular and radiology enterprise imaging and reporting...
Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21
Feature | EP Lab | July 28, 2021
July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them...
The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.

The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.

News | EP Lab | July 27, 2021
July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG)...

An IVC filter seen under X-ray, left. Right, two sizes of the Philips excimer laser technology currently on the U.S. market for EP lead extraction. The CO2 laser technology is able to gently ablate scar tissue encasing leads to enable their extraction. 

News | Inferior Vena Cava Filters | July 27, 2021
July 27, 2021 — The U.S Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a laser...
Schematic illustration of a pre-vascularized stem cell patch having multiple stem cell-laden bio-inks to encorage heart cell regrowth at infarct areas. With permission from Elsevier. Read the original article.Jinah Jang, Reprinted from Biomaterials, Vol 112, Jinah Jang et al., 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair, Pages 264-274, Copyright (2017),

Schematic illustration of a pre-vascularized stem cell patch having multiple stem cell-laden bio-inks to encorage heart cell regrowth at infarct areas. With permission from Elsevier. Read the original

News | Medical 3-D Printing | July 27, 2021
July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks,...
Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.
News | EP Lab | July 27, 2021
July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1]...
Images or a digital twin mitral valve of a patient created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The right image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One https:/

Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One.

Feature | Cardiovascular Ultrasound | July 26, 2021 | By Dave Fornell, Editor
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in...